On Invalid Date, Enzo Biochem (NYSE: ENZ) reported Q4 2023 earnings per share (EPS) of -$0.06, up 73.91% year over year. Total Enzo Biochem earnings for the quarter were -$3.06 million. In the same quarter last year, Enzo Biochem's earnings per share (EPS) was -$0.23.
As of Q2 2024, Enzo Biochem's earnings has grown year over year. Enzo Biochem's earnings in the past year totalled $32.57 million.
What is ENZ's earnings date?
Enzo Biochem's earnings date is Invalid Date. Add ENZ to your watchlist to be reminded of ENZ's next earnings announcement.
What was ENZ's revenue last quarter?
On Invalid Date, Enzo Biochem (NYSE: ENZ) reported Q4 2023 revenue of $8.55 million up 13.83% year over year. In the same quarter last year, Enzo Biochem's revenue was $7.51 million.
What was ENZ's revenue growth in the past year?
As of Q2 2024, Enzo Biochem's revenue has grown null year over year. Enzo Biochem's revenue in the past year totalled $12.81 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.